LYTIR

Company · HEPA

Hepion Pharmaceuticals, Inc.

HEPA is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 6 occasions ($835K); 8 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $835K in total; Insider sales: $0 in total.Aug: Insider purchases $825KSep: Insider purchases $10KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $835KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Vincent S. LoPriore, Executive Chairman bought on 1 day latest Aug 3, 2026 bought $500K
  2. Sireesh Appajosyula, Chief Operating Officer bought on 1 day latest Aug 3, 2026 bought $100K
  3. Michael J. Purcell bought on 1 day latest Aug 3, 2026 bought $100K
  4. Gary S. Stetz, Interim CEO bought on 1 day latest Aug 3, 2026 bought $100K
  5. Gary S. Stetz II bought on 1 day latest Aug 3, 2026 bought $25K
  6. Danina Fisher bought on 1 day latest Sep 29, 2026 bought $10K
Every trade (6)
  1. BUYDanina Fisher bought Sep 29, 2026 200,000 shares filing $10K
  2. BUYVincent S. LoPriore, Executive Chairman bought Aug 3, 2026 10,000,000 shares 2 legs combined filing $500K
  3. BUYSireesh Appajosyula, Chief Operating Officer bought Aug 3, 2026 2,000,000 shares filing $100K
  4. BUYMichael J. Purcell bought Aug 3, 2026 2,000,000 shares filing $100K
  5. BUYGary S. Stetz, Interim CEO bought Aug 3, 2026 2,000,000 shares filing $100K
  6. BUYGary S. Stetz II bought Aug 3, 2026 500,000 shares filing $25K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Gravitas Collective Corp. filed Oct 26, 2026 Schedule 13D may seek influence 25,000,000 shares filing 19.9%
  2. Kenneth Rickel filed Oct 21, 2026 Schedule 13G/A passive 7,250,000 shares filing 7.2%
  3. KI Holdings Ltd. filed Sep 16, 2026 Schedule 13D/A may seek influence 10,000,000 shares filing 10.2%
  4. Kenneth Rickel filed Sep 15, 2026 Schedule 13G passive 5,250,000 shares filing 5.7%
  5. LoPriore Vincent S filed Aug 20, 2026 Schedule 13D/A may seek influence 21,000,000 shares filing 21.4%
  6. Appajosyula Sireesh filed Aug 20, 2026 Schedule 13D may seek influence 5,250,000 shares filing 5.7%
  7. Stetz Gary S. filed Aug 20, 2026 Schedule 13D may seek influence 5,250,000 shares filing 5.7%
  8. Black Global 5 LLC filed Aug 7, 2026 Schedule 13D may seek influence 10,000,000 shares filing 11.1%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Unregistered sales of equity securities; Departure or appointment of directors or officers filing Oct 9, 2026
  2. Amendments to articles or bylaws; change in fiscal year filing Oct 2, 2026
  3. Change in certifying accountant filing Sep 28, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.